FDA orders Gynecology, Reproductive Endocrinology and Fertility Institute to immediately stop manufacturing cell/tissue products after an October insp...
FDA announces a 2/25 public workshop entitled Evolving Role of Artificial Intelligence in Radiological Imaging.
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Novo Nordisks Ozempic.
FDA Review posts the Federal Register notices for the week ending 11/29/2019.
Federal Register notice: FDA debars Tzvi Lexier for 10 years from importing any drug into the U.S. because he was convicted for conspiracy to smuggle ...
FDA withdraws approval of six ANDAs from multiple applicants after they notified the agency that the drug products were no longer marketed.
Federal Register notice: FDA makes available a draft guidance entitled Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insul...